Skip to main content

Adverse Childhood Experiences Linked to Headache in Adulthood

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Oct. 27, 2023 -- Adverse childhood experiences (ACEs) are associated with primary headache in adulthood, according to a review published online Oct. 25 in Neurology.

Claudia Sikorski, Ph.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues conducted a systematic review to examine the pooled effect of one or more ACEs on primary headache disorders in adulthood. Theories that describe how ACEs impact human development and disease across the life course were included in a narrative review. Thirty-two studies were identified; 28 were eligible for meta-analysis (154,739 participants in 19 countries).

The researchers found that occurrence of one or more ACEs was associated with primary headaches (pooled odds ratio, 1.48). The odds of primary headache increased as the number of ACEs increased (odds ratios, 1.24 for one ACE to 2.09 for four or more ACEs). A neurodevelopmental theory that classifies ACEs into threat or deprivation was tested for the narrative review; both threat and deprivation were independently associated with primary headaches (odds ratios, 1.46 and 1.35, respectively).

"Traumatic events in childhood can have serious health implications later in life," coauthor Catherine Kreatsoulas, Ph.D., of the Harvard T.H. Chan School of Public Health in Boston, said in a statement. "Our meta-analysis confirms that childhood traumatic events are important risk factors for headache disorders in adulthood, including migraine, tension headaches, cluster headaches, and chronic or severe headaches. This is a risk factor that we cannot ignore."

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

Targeted Diagnostic Botox Injections Can Identify Trigger Sites for Migraine

THURSDAY, May 9, 2024 -- Diagnostic targeted Botox injections have high positive predictive value for migraine trigger site localization, according to a study published in the May...

Use of Acid-Suppression Therapy Linked to Migraine, Severe Headache

FRIDAY, April 26, 2024 -- Use of acid-suppression therapy is associated with higher odds of migraine or severe headache, according to a study published online April 24 in...

American Academy of Neurology, April 13-18

The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.